Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

NASDAQ:DCBO - Nasdaq - CA25609L1058 - Common Stock - Currency: USD

31.13  -0.52 (-1.64%)

After market: 31.13 0 (0%)

Fundamental Rating

6

Taking everything into account, DCBO scores 6 out of 10 in our fundamental rating. DCBO was compared to 283 industry peers in the Software industry. DCBO has only an average score on both its financial health and profitability. DCBO is growing strongly while it is still valued neutral. This is a good combination! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
DCBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO's Return On Assets of 11.66% is amongst the best of the industry. DCBO outperforms 89.05% of its industry peers.
With an excellent Return On Equity value of 43.94%, DCBO belongs to the best of the industry, outperforming 95.05% of the companies in the same industry.
DCBO has a Return On Invested Capital of 21.50%. This is amongst the best in the industry. DCBO outperforms 94.35% of its industry peers.
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROIC 21.5%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

Looking at the Profit Margin, with a value of 10.34%, DCBO is in the better half of the industry, outperforming 74.20% of the companies in the same industry.
With a decent Operating Margin value of 9.40%, DCBO is doing good in the industry, outperforming 74.20% of the companies in the same industry.
With an excellent Gross Margin value of 80.94%, DCBO belongs to the best of the industry, outperforming 83.39% of the companies in the same industry.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
DCBO has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, DCBO has more shares outstanding
Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 3.83. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
DCBO has a better Altman-Z score (3.83) than 66.78% of its industry peers.
DCBO has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.04, DCBO belongs to the best of the industry, outperforming 82.33% of the companies in the same industry.
DCBO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
DCBO has a Debt to Equity ratio of 0.00. This is in the better half of the industry: DCBO outperforms 67.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 3.83
ROIC/WACC2.04
WACC10.52%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.15. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DCBO (1.15) is worse than 67.84% of its industry peers.
A Quick Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO's Quick ratio of 1.15 is on the low side compared to the rest of the industry. DCBO is outperformed by 66.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
The Revenue has grown by 19.96% in the past year. This is quite good.
The Revenue has been growing by 39.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
DCBO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.94% yearly.
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year9.84%
Revenue Next 2Y9.66%
Revenue Next 3Y9.43%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

DCBO is valuated quite expensively with a Price/Earnings ratio of 28.30.
DCBO's Price/Earnings ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 67.14% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.85. DCBO is around the same levels.
With a Price/Forward Earnings ratio of 21.47, DCBO is valued on the expensive side.
DCBO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 74.56% of the companies in the same industry.
DCBO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.3
Fwd PE 21.47
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

DCBO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 71.02% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DCBO is valued a bit cheaper than the industry average as 70.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 32.69
EV/EBITDA 33.14
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 21.71% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (8/19/2025, 8:00:01 PM)

After market: 31.13 0 (0%)

31.13

-0.52 (-1.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners36.86%
Inst Owner Change-8.75%
Ins Owners1.46%
Ins Owner ChangeN/A
Market Cap896.54M
Analysts78.67
Price Target29.32 (-5.81%)
Short Float %1.88%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.55%
Min EPS beat(2)26.05%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)25.39%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)-11.33%
EPS beat(12)10
Avg EPS beat(12)140.75%
EPS beat(16)12
Avg EPS beat(16)97.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-0.47%
PT rev (1m)0.33%
PT rev (3m)-16.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.23%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)-1.71%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE 28.3
Fwd PE 21.47
P/S 4.02
P/FCF 32.69
P/OCF 31.16
P/B 17.1
P/tB 24.32
EV/EBITDA 33.14
EPS(TTM)1.1
EY3.53%
EPS(NY)1.45
Fwd EY4.66%
FCF(TTM)0.95
FCFY3.06%
OCF(TTM)1
OCFY3.21%
SpS7.74
BVpS1.82
TBVpS1.28
PEG (NY)0.72
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROCE 36.68%
ROIC 21.5%
ROICexc N/A
ROICexgc N/A
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
FCFM 12.31%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0
Cap/Depr 39.83%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 118.32%
Profit Quality 119.04%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 3.83
F-Score8
WACC10.52%
ROIC/WACC2.04
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year9.84%
Revenue Next 2Y9.66%
Revenue Next 3Y9.43%
Revenue Next 5Y24.94%
EBIT growth 1Y347.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.58%
FCF growth 1Y2197.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1283.74%
OCF growth 3YN/A
OCF growth 5YN/A